Joep Perk
Biographic Data
| ID | 6359958 |
|---|---|
| NAME | Joep Perk |
| GIVEN NAMES | Joep |
| FAMILY NAME | Perk |
| SIGNATURE | PERK J |
| AFFILIATIONS | Linnaeus University |
| VERIFIED | No |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 7 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
ESC Guidelines on cardiovascular disease prevention in clinical practice
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to goo…
ESC/ESH Guidelines for the management of arterial hypertension
The current background information and detailed discussion of the data can be found in ESC CardioMed - Section 44 Systemic hypertension ... ... Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily pr…
European Guidelines on cardiovascular disease prevention in clinical practice
No abstract available.
The MacNew Heart Disease Health-Related Quality of Life Questionnaire
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
C-reactive protein CURE Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD cardiovascular disease DALYs disability-adjusted life years DBP diastolic blood
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The Eurika Study
Lack of control of CVD risk factors was responsible for almost 30% of the risk of CVD death among patients participating in the EURIKA Study
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (Eurika)
Primary prevention of CVD is an extremely important clinical issue, with preventable circulatory diseases remaining the leading cause of major disease burden. The EURIKA study will provide key information to assess effectiveness of and attitudes toward primary prevention of CVD in Europe. A transnational study creates opportunities for benchmarking good clinical practice across countries and improving outcomes. (ClinicalTrials.gov number, NCT0088…
No prominent works on this page.
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (Eurika)
Primary prevention of CVD is an extremely important clinical issue, with preventable circulatory diseases remaining the leading cause of major disease burden. The EURIKA study will provide key information to assess effectiveness of and attitudes toward primary prevention of CVD in Europe. A transnational study creates opportunities for benchmarking good clinical practice across countries and improving outcomes. (ClinicalTrials.gov number, NCT0088…
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The Eurika Study
Lack of control of CVD risk factors was responsible for almost 30% of the risk of CVD death among patients participating in the EURIKA Study
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
C-reactive protein CURE Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD cardiovascular disease DALYs disability-adjusted life years DBP diastolic blood
The MacNew Heart Disease Health-Related Quality of Life Questionnaire
European Guidelines on cardiovascular disease prevention in clinical practice
No abstract available.
ESC/ESH Guidelines for the management of arterial hypertension
The current background information and detailed discussion of the data can be found in ESC CardioMed - Section 44 Systemic hypertension ... ... Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily pr…
ESC Guidelines on cardiovascular disease prevention in clinical practice
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to goo…
Medicine (7 works) · Cardiac Health and Mental Health (5 works) · Blood Pressure and Hypertension Studies (3 works) · Disease (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Intensive care medicine (3 works) · Internal Medicine (3 works) · Lipoproteins and Cardiovascular Health (3 works) · Myocardial infarction (3 works) · Public health (3 works)